Is Your Company Worth the Risk: Making Your Start-up Device or Biotech Company Attractive for Investors.

What attracts venture capitalists to fund certain start-ups and not others? Many of today's leading medical device and biotech companies began as start-ups funded by VCs who took a risk. This seminar will provide a forum for discussion of how lower-risk strategies combined with successful commercial marketing plans can be achieved to help entrepreneurs attract the capital vital to a start-up's success. Members of the business community who have played critical roles in bringing start-ups to fruition will provide key expertise on this subject.

Highlights that will be discussed by this panel include:

• The real-life experiences of CEOs in growing an early-stage company
• What criteria do investors use to evaluate a biotech or device start-up?
• At what stage should VCs be approached?
• What concerns VCs when considering their next investment?
• How important is it for the start-up to have other products in the pipeline?
• What role does patent protection play in the consideration of funding?
• How to differentiate your start-up to make it attractive for funding

Speakers:

 

David W. Anderson

President and CEO, Gentis, Inc.

David R. King

Venture Partner, Quaver BioVentures

Please join us at The Union League for this panel presentation. A continental breakfast will be served at 7:30am.

To Register: Click Here